Portfolio company
Vivan Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides personalised cancer drug screening reports for oncologists and patients using genomics and fruit fly disease models.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Oncosyne
This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
D2G Oncology
This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.
PreComb
This company develops a precision oncology platform using patient-derived microtumour models and automated analysis to predict drug responses for biopharmaceutical firms and clinical institutions.
Tempus
This company provides data-driven genomic sequencing and clinical analysis tools to healthcare providers and pharmaceutical companies for personalised patient care and drug development.
ScreenIn3D Limited
This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.
Known Medicine
This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.